Judit Oláh

Dr. Judit Oláh

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
TRTobias Rumpf
Tobias Rumpf
MSMatthias Schiedel
Matthias Schiedel
BMBerin Karaman Mayack
Berin Karaman Mayack
CRClaudia Roessler
Claudia Roessler
BNBrian J. North
Brian J. North
MJManfred Jung
Manfred Jung
Sirtuins are a highly conserved class of NAD+-dependent lysine deacylases. The human isotype Sirt2 has been implicated in the pathogenesis of cancer, inflammation and neurodegeneration, which makes the modulation of Sirt2 activity a promising strategy for pharmaceutical intervention. A rational basis for the development of optimized Sirt2 inhibitors is lacking so far. Here we present high-resolution structures of human Sirt2 in complex with highly selective drug-like inhibitors that show a unique inhibitory mechanism. Potency and the unprecedented Sirt2 selectivity are based on a ligand-induced structural rearrangement of the active site unveiling a yet-unexploited binding pocket. Application of the most potent Sirtuin-rearranging ligand, termed SirReal2, leads to tubulin hyperacetylation in HeLa cells and induces destabilization of the checkpoint protein BubR1, consistent with Sirt2 inhibition in vivo. Our structural insights into this unique mechanism of selective sirtuin inhibition provide the basis for further inhibitor development and selective tools for sirtuin biology.

17 April 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MSMatthias Schiedel
Matthias Schiedel
DHDaniel Herp
Daniel Herp
SHSören Hammelmann
Sören Hammelmann
SSSören Swyter
Sören Swyter
ALAttila Lehotzky
Attila Lehotzky
MJManfred Jung
Manfred Jung

1 December 2009 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
FOFerenc Orosz
Ferenc Orosz
JOJudit Oláh
Judit Oláh
JOJudit Ovádi
Judit Ovádi

1 September 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JOJudit Oláh
Judit Oláh
OVOrsolya Vincze
Orsolya Vincze
DVDezső Virók
Dezső Virók
DSDóra Simon
Dóra Simon
ZBZsolt Bozsó
Zsolt Bozsó
JOJudit Ovádi
Judit Ovádi
The disordered tubulin polymerization promoting protein (TPPP/p25) was found to be co-enriched in neuronal and glial inclusions with α-synuclein in Parkinson disease and multiple system atrophy, respectively; however, co-occurrence of α-synuclein with β-amyloid (Aβ) in human brain inclusions has been recently reported, suggesting the existence of mixed type pathologies that could result in obstacles in the correct diagnosis and treatment. Here we identified TPPP/p25 as an interacting partner of the soluble Aβ oligomers as major risk factors for Alzheimer disease using ProtoArray human protein microarray. The interactions of oligomeric Aβ with proteins involved in the etiology of neurological disorders were characterized by ELISA, surface plasmon resonance, pelleting experiments, and tubulin polymerization assay. We showed that the Aβ42 tightly bound to TPPP/p25 (Kd = 85 nm) and caused aberrant protein aggregation by inhibiting the physiologically relevant TPPP/p25-derived microtubule assembly. The pair-wise interactions of Aβ42, α-synuclein, and tubulin were found to be relatively weak; however, these three components formed soluble ternary complex exclusively in the absence of TPPP/p25. The aggregation-facilitating activity of TPPP/p25 and its interaction with Aβ was monitored by electron microscopy with purified proteins by pelleting experiments with cell-free extracts as well as by confocal microscopy with CHO cells expressing TPPP/p25 or amyloid. The finding that the interaction of TPPP/p25 with Aβ can produce pathological-like aggregates is tightly coupled with unusual pathology of the Alzheimer disease revealed previously; that is, partial co-localization of Aβ and TPPP/p25 in the case of diffuse Lewy body disease with Alzheimer disease.

17 November 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
LTL. Tirián
L. Tirián
EHE. Hlavanda
E. Hlavanda
JOJudit Oláh
Judit Oláh
IHIstvan Horvath
Istvan Horvath
FOF. Orosz
F. Orosz
JOJudit Ovádi
Judit Ovádi
Recently, we isolated from bovine brain a protein, TPPP/p25 and identified as p25, a brain-specific protein that induced aberrant tubulin assemblies. The primary sequence of this protein differs from that of other proteins identified so far; however, it shows high homology with p25-like hypothetical proteins sought via blast . Here, we characterized the binding of TPPP/p25 to tubulin by means of surface plasmon resonance; the kinetic parameters are as follows: k on , 2.4 × 10 4 M –1 ·s –1 ; k off , 5.4 × 10 –3 s –1 ; and K d , 2.3 × 10 –7 M. This protein at substoichometric concentration promotes the polymerization of tubulin into double-walled tubules and polymorphic aggregates or bundles paclitaxel-stabilized microtubules as judged by quantitative data of electron and atomic force microscopies. Injection of bovine TPPP/p25 into cleavage Drosophila embryos expressing tubulin–GFP fusion protein reveals that TPPP/p25 inhibits mitotic spindle assembly and nuclear envelope breakdown without affecting other cellular events like centrosome replication and separation, microtubule nucleation by the centrosomes, and nuclear growth. GTP counteracts TPPP/p25 both in vitro and in vivo .

12 June 2002 in Biochemistry
Verified
Journal Article
Closed access
EHEmma Hlavanda
Emma Hlavanda
JKJános Kovács
János Kovács
JOJudit Oláh
Judit Oláh
FOFerenc Orosz
Ferenc Orosz
KMKatalin F. Medzihradszky
Katalin F. Medzihradszky
JOJudit Ovádi
Judit Ovádi